Medtronic (MDT) Stock Forecast for 2024–2028. Sell or Buy Prediction

Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Medtronic (MDT) Stock Forecast for 2024–2028. Sell or Buy?

Updated: July 24, 2024 (01:42)

Sector: Healthcare

The share price of Medtronic plc. (MDT) now

Latest session on the 23rd of July for
Medtronic plc. is positive
Trading Volume: 5021814
Open: 79.45 /  High: 79.655 /  Low: 78.805
What analysts predict: $92.43
52-week High/Low: $87.96 / $67.11

50/200 Day Moving Average: $80.93 / $81.28

This figure corresponds to the Average Price over the previous 50/200 days. For Medtronic stocks, the 50-day moving average is the resistance level today.

For Medtronic stocks, the 200-day moving average is the resistance level today.

Are you interested in Medtronic plc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Medtronic stock price in 2024, 2025, 2026, 2027, 2028. How much will one Medtronic share be worth in 2024 - 2028?

When should I take profit in Medtronic stock? When should I record a loss on Medtronic stock? What are analysts' forecasts for Medtronic stock? What is the future of Medtronic stock? We forecast Medtronic stock performance using neural networks based on historical data on Medtronic stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Medtronic stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Medtronic shares. This happens once a day.

Historical and forecast chart of Medtronic stock

The chart below shows the historical price of Medtronic stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Medtronic stock price can be found in the table below.

Long-term forecasts by years.

Trend: Bullish
Jul 17, 2024
### Medtronic Stock Forecast: Key Factors Influencing Price Changes

As we look ahead to forecast Medtronic (MDT) stock prices, several pivotal factors will play major roles in shaping its trajectory. Analysts must keep a keen eye on these elements to make accurate predictions.

Upcoming Events and Influential Factors

One of the most critical factors influencing MDT stock prices is the market sentiment surrounding GLP-1 drugs developed by competitors like Eli Lilly and Novo Nordisk. The potential impact of these drugs on Medtronic’s diabetes and obesity treatment segments could significantly hurt their revenue streams, reflecting negatively on stock prices due to market fear.

Additionally, Medtronic’s current stock valuation, with a forward PE ratio of 14.4 well below its historical PE of 18.2, presents an attractive buying opportunity. Investors should monitor this undervaluation, as the market correcting this discrepancy could lead to a positive move in MDT stock prices.

Strong top-line sales growth, particularly a 5.4% YoY organic revenue increase, and a robust product pipeline, signal long-term revenue expansion. This growth, alongside a solid track record of 47 consecutive years of dividend increases and a high 3.6% yield, showcases financial stability and shareholder commitment. Such factors attract long-term, income-focused investors.

Finally, Medtronic's strong financial health, with an 'A' credit rating and high profitability margins, reinforces investor confidence. Analysts leveraging these insights can more accurately assess MDT's stock future by considering:

  • The competitive impact of GLP-1 drugs
  • Current undervaluation versus historical averages
  • Consistent top-line sales growth
  • A proven dividend growth track record
  • Robust financial health and profitability

By keeping these factors in focus, analysts can craft well-rounded and precise forecasts for Medtronic stock.

Review the original Analysis
About author

Trend: Bullish
Jul 16, 2024
## Medtronic Stock Forecast: The Key Drivers of Future Growth

When forecasting MDT stock rates, several influencing factors and upcoming events need close attention. Medtronic's dominant market leadership and robust product pipeline play a pivotal role in its investment potential. This strong positioning, particularly in high-growth segments like cardiovascular and neuroscience, is poised to drive stock prices upward as new products gain regulatory approval and launch successfully.

Core Drivers for MDT Stock Performance

Analysts can leverage Medtronic's consistent financial performance and earnings growth to make precise stock price predictions. The company's ability to sustain strong gross margins and free cash flow, while investing heavily in R&D, assures investors of continued profitability. This consistent financial health, coupled with favorable post-COVID market recovery, bodes well for future stock price appreciation.

  • Capital Allocation and Shareholder Returns: Medtronic's shareholder-friendly approach, evidenced by regular share buybacks and dividends, enhances investor sentiment and is likely to drive stock prices up.
  • Valuation Metrics: Trading below historical averages, Medtronic offers an attractive entry point for investors, indicating potential for significant price appreciation.
  • Regulatory Approvals: Key milestones, such as the approval of the Affera system, can act as catalysts for stock price increases, making regulatory success a critical short-term factor.
  • Macro-Economic Conditions: Broader economic stability and positive industry trends in healthcare spending and technological advancements further impact stock performance.

Overall, analysts forecasting Medtronic stock can develop accurate predictions by focusing on these key factors. By closely monitoring the company's financial health, product pipeline advancements, and regulatory milestones, they can anticipate future stock movements effectively. As economic conditions and industry dynamics align favorably, Medtronic stands out as a compelling investment opportunity.

Whether considering MDT stock buy or sell decisions, these insights provide a comprehensive understanding for making informed investment choices in Medtronic.

Review the original Analysis
About author

Unlocking the Potential: Why Medtronic's Future Looks Bright

Trend: Bullish
Jun 14, 2024

In the bustling world of stock investments, predicting the trajectory of company shares is akin to uncovering a treasure map where X marks the spot. Medtronic (MDT), noted for its stature as a deep value Dividend Aristocrat, presents a compelling case for investors eyeing to capitalize on the healthcare innovation frontier. As analysts gaze into their financial crystal balls, a blend of pivotal events and factors emerge, promising to steer the MDT stock forecast towards fruitful realms.

Charting the Course: Key Factors to Navigate MDT Stock Predictions

Foremost, Medtronic's heartening financial performance and robust revenue growth in core businesses shine as beacons, signaling an upward trajectory for MDT stock prices. Such growth not only reflects the company's current strength but also lays down a solid foundation for future earnings. Equally compelling are the recent product launches and innovations, including the MiniMed 780G insulin pump and Simplicity Spyral treatment. These advancements are critical markers for analysts aiming to craft an accurate MDT stock price prediction, underpinning potential market share gains and revenue upticks.

Additionally, the allure of Medtronic's stock is magnified by its current valuation dipped below historical averages, suggesting a tantalizing buy opportunity. Grasping this valuation anomaly can enable savvy investors to anticipate a reversion to higher multiples, thereby generating lucrative returns. Furthermore, the irresistible dividend yield and secure payout ratio of Medtronic fortify its position as a compelling MDT stock buy or sell consideration. This blend of income reliability and growth prospect serves as a magnet, attracting a broader investor base.

To encapsulate, the forecasting prism for MDT stock rates intricately intertwines financial performance, innovative product launches, enticing valuation, and dividend appeal. Each factor, individually and collectively, holds the power to sway MDT's stock forecast, guiding analysts and investors through the labyrinth of stock market predictions towards a promising investment horizon.

Review the original Analysis
About author

Medtronic is a large medical device company headquartered in Dublin, Ireland. It is one of the largest medical device companies. Works in over 140 countries. Medtronic has six main divisions, each of which develops and manufactures devices and treatments for a variety of chronic conditions including heart failure, Parkinson’s disease, urinary incontinence, Down’s syndrome, obesity, chronic pain, diabetes and others, for a total of more than 30 different diseases.

In 2017, the company earned more than $ 29 billion, which is 9 billion more than in 2015, the net income for the 2017 financial year of the company increased by $ 1 billion compared to 2015 and amounted to more than $ 5 billion.

Medtronic was founded in 1949 as a medical device repair company in a garage in northeastern Minneapolis by Earl Bakken and Palmer Hermundsl. While working for the company, Earl Bakken met Dr. Walton Lillehei, one of the first cardiac surgeons. Lillehei was disappointed with the pacemakers of the time that had to be plugged in, especially after the 1957 power outage on Halloween. Lillehei then proposed to Bakken the idea of ​​a battery-operated pacemaker.

Official site of the company

Medtronic daily forecast for a month

Date Target Pes. Opt. Vol., %
Jul 25 82.09 81.76 83.35 1.95
Jul 26 81.78 80.55 82.69 2.66
Jul 27 82.30 81.15 82.75 1.97
Jul 28 83.01 82.36 83.52 1.41
Jul 29 82.53 82.07 83.63 1.91
Jul 30 83.62 83.25 83.95 0.84
Jul 31 83.68 83.13 84.62 1.79
Aug 01 83.47 82.16 84.35 2.66
Aug 02 84.47 84.06 85.46 1.67
Aug 03 85.23 84.61 86.34 2.03
Aug 04 83.71 82.72 84.80 2.51
Aug 05 83.18 82.29 84.16 2.26
Aug 06 83.06 81.96 83.47 1.84
Aug 07 84.72 83.74 85.82 2.49
Aug 08 83.89 82.73 84.98 2.72
Aug 09 83.07 81.82 83.95 2.60
Aug 10 84.15 83.12 85.12 2.41
Aug 11 85.53 84.71 86.30 1.88
Aug 12 84.84 83.86 86.05 2.61
Aug 13 83.84 82.67 84.35 2.03
Aug 14 83.17 81.89 83.54 2.01
Aug 15 81.87 80.74 83.18 3.02
Aug 16 82.33 81.15 83.42 2.80
Aug 17 83.21 82.01 84.44 2.96
Aug 18 84.00 82.88 85.30 2.92
Aug 19 84.49 83.33 85.32 2.39
Aug 20 83.43 82.38 83.81 1.74
Aug 21 83.04 81.95 83.42 1.80
Aug 22 83.46 82.67 84.31 1.98
Aug 23 82.12 81.48 82.73 1.53

Medtronic Daily Price Targets

Medtronic Stock Forecast 07-25-2024.

Forecast target price for 07-25-2024: $82.09.
Positive dynamics for Medtronic shares will prevail with possible volatility of 1.911%.
Pessimistic target level: 81.76
Optimistic target level: 83.35

Medtronic Stock Forecast 07-26-2024.

Forecast target price for 07-26-2024: $81.78.
Negative dynamics for Medtronic shares will prevail with possible volatility of 2.591%.
Pessimistic target level: 80.55
Optimistic target level: 82.69

Medtronic Stock Forecast 07-27-2024.

Forecast target price for 07-27-2024: $82.30.
Positive dynamics for Medtronic shares will prevail with possible volatility of 1.930%.
Pessimistic target level: 81.15
Optimistic target level: 82.75

Medtronic Stock Forecast 07-28-2024.

Forecast target price for 07-28-2024: $83.01.
Positive dynamics for Medtronic shares will prevail with possible volatility of 1.391%.
Pessimistic target level: 82.36
Optimistic target level: 83.52

Medtronic Stock Forecast 07-29-2024.

Forecast target price for 07-29-2024: $82.53.
Negative dynamics for Medtronic shares will prevail with possible volatility of 1.875%.
Pessimistic target level: 82.07
Optimistic target level: 83.63

Medtronic Stock Forecast 07-30-2024.

Forecast target price for 07-30-2024: $83.62.
Positive dynamics for Medtronic shares will prevail with possible volatility of 0.837%.
Pessimistic target level: 83.25
Optimistic target level: 83.95

MDT (MDT) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Aug. 77.33 72.85 79.42 8.28
Sep. 76.64 74.03 81.08 8.70
Oct. 74.88 69.63 79.82 12.76
Nov. 76.37 74.69 80.57 7.30
Dec. 74.31 70.97 77.28 8.17

Medtronic forecast for this year

Medtronic Stock Prediction for Aug 2024

An downtrend is forecast for this month with an optimal target price of $77.334. Pessimistic: $72.85. Optimistic: $79.42

Medtronic Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $76.638. Pessimistic: $74.03. Optimistic: $81.08

Medtronic Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $74.8754. Pessimistic: $69.63. Optimistic: $79.82

Medtronic Stock Prediction for Nov 2024

An uptrend is forecast for this month with an optimal target price of $76.3729. Pessimistic: $74.69. Optimistic: $80.57

Medtronic Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $74.3108. Pessimistic: $70.97. Optimistic: $77.28

Medtronic (MDT) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 73.94 71.94 77.56 7.25
Feb 74.31 72.15 77.95 7.44
Mar 74.53 72.07 79.45 9.29
Apr 77.07 72.13 82.85 12.93
May 78.45 76.88 80.96 5.04
Jun 73.43 68.29 76.22 10.40
Jul 68.88 64.20 72.74 11.74
Aug 75.29 72.35 77.02 6.06
Sep 81.53 75.83 83.41 9.09
Oct 88.63 82.60 92.97 11.15
Nov 88.89 82.14 94.76 13.32
Dec 87.03 84.85 91.99 7.76

Medtronic (MDT) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 85.46 79.39 92.30 13.98
Feb 82.21 76.70 86.57 11.40
Mar 75.22 69.58 81.02 14.11
Apr 73.80 70.11 77.63 9.70
May 73.94 70.10 76.01 7.78
Jun 67.81 65.64 73.16 10.29
Jul 69.70 64.55 73.33 11.98
Aug 67.19 65.85 68.87 4.39
Sep 73.65 70.26 78.06 10.00
Oct 74.23 70.52 77.87 9.44
Nov 76.68 73.00 79.91 8.64
Dec 72.93 67.97 75.92 10.47

Medtronic (MDT) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 68.33 63.75 72.77 12.39
Feb 66.08 64.43 70.44 8.54
Mar 71.43 68.93 73.00 5.58
Apr 69.29 65.34 74.69 12.52
May 70.60 66.58 73.36 9.24
Jun 77.03 72.95 79.65 8.41
Jul 77.34 72.46 79.89 9.29
Aug 82.60 79.70 86.97 8.36
Sep 79.21 76.28 82.93 8.02
Oct 75.57 73.37 79.65 7.87
Nov 73.07 69.93 78.48 10.89
Dec 65.76 63.00 67.61 6.81

Medtronic (MDT) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 69.05 67.05 72.30 7.26
Feb 72.02 66.91 77.57 13.74
Mar 68.56 64.04 74.05 13.52
Apr 75.15 73.19 77.55 5.62
May 78.90 74.25 84.27 11.89
Jun 76.14 71.04 78.12 9.06
Jul 81.32 78.47 86.28 9.05
Aug 79.78 76.42 85.68 10.80
Sep 81.53 76.31 88.05 13.33
Oct 85.93 81.29 88.25 7.89
Nov 84.39 80.67 87.51 7.81
Dec 87.76 85.39 89.52 4.61

Medtronic information and performance

Medtronic Address


Market Capitalization: 101 914 821 000 $

Market capitalization of the Medtronic plc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of MDT shares in the company outstanding by the market price of one share.

EBITDA: 9 056 000 000 $

EBITDA of Medtronic is earnings before interest, income tax and depreciation of assets.

PE Ratio: 28.8

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 1.518

Price/earnings to growth

DPS: 2.76

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0352

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 2.76

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.445
Quarterly Revenue Growth YOY: 0.005
Trailing PE: 28.8

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 14.66

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 3.814

Enterprise Value (EV) /Revenue

EV To EBITDA: 13.84

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 1282270000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Medtronic (MDT) stock dividend

Medtronic last paid dividends on 06/28/2024. The next scheduled payment will be on 07/12/2024. The amount of dividends is $2.76 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.

Related stocks from Healthcare sector


All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.